BioVersys AG | WebDisclosure

PRESS RELEASE

published on 03/14/2025 at 07:00, 10 months 17 days ago

BIOVERSYS ANNOUNCES REPORTING DATE FOR FULL-YEAR 2024 FINANCIAL RESULTS AND EVENT DETAILS
BioVersys AG announces reporting date for full-year 2024 financial results and event details, including a conference call and webcast on March 26, 2025. The company focuses on developing novel antibacterial products for MDR bacteria

Financial Results Conference Call BioVersys AG Antibacterial Products MDR Bacteria
BRIEF

published on 03/10/2025 at 07:05, 10 months 21 days ago

BioVersys AG annonce l'exercice partiel de son option de surallocation

Bourse Suisse SIX Option De Surallocation Entreprise Biopharmaceutique Introduction En Bourse De BioVersys Produits Antibactériens
BRIEF

published on 03/10/2025 at 07:05, 10 months 21 days ago

BioVersys AG Announces Partial Exercise of Over-Allotment Option

Biopharmaceutical Company SIX Swiss Exchange Over-allotment Option BioVersys IPO Antibacterial Products
PRESS RELEASE

published on 03/10/2025 at 07:00, 10 months 21 days ago

Bioversys announces partial exercise of over-allotment option
BioVersys announces partial exercise of over-allotment option following successful IPO on the SIX Swiss Exchange, raising total gross proceeds of CHF76.7 million

Biopharmaceutical Company IPO Over-allotment Option BioVersys Multidrug-resistant Bacteria
BRIEF

published on 02/11/2025 at 07:05, 11 months 20 days ago

BioVersys fait progresser le programme BV500 NTM avec le soutien du CF AMR Syndicate

Fibrose Kystique BioVersys SA Programme NTM Assistance LifeArc Chimie De L'ansamycine
BRIEF

published on 02/11/2025 at 07:05, 11 months 20 days ago

BioVersys Advances BV500 NTM Program with CF AMR Syndicate Support

Cystic Fibrosis BioVersys AG NTM Program LifeArc Support Ansamycin Chemistry
PRESS RELEASE

published on 02/11/2025 at 07:00, 11 months 20 days ago

BIOVERSYS SUCCESSFULLY ADVANCES BV500 NTM PROGRAM WITH CONTINUED SUPPORT FROM CF AMR SYNDICATE
BioVersys advances BV500 NTM program with continued support from CF AMR Syndicate, developing therapies for NTM lung disease in CF patients. Company focuses on antibacterial products against MDR bacteria

BioVersys BV500 NTM Program CF AMR Syndicate NTM Lung Disease MDR Bacteria
BRIEF

published on 02/06/2025 at 07:05, 11 months 25 days ago

BioVersys finalise avec succès son introduction en bourse à 36 CHF par action

Capitalisation Boursière Introduction En Bourse Bourse Suisse SIX BioVersys SA Médicaments Antibactériens
BRIEF

published on 02/06/2025 at 07:05, 11 months 25 days ago

BioVersys Successfully Completes IPO at CHF 36 per Share

IPO Market Capitalization SIX Swiss Exchange BioVersys AG Antibacterial Drugs
PRESS RELEASE

published on 02/06/2025 at 07:00, 11 months 25 days ago

BIOVERSYS SUCCESSFULLY COMPLETES ITS IPO AT CHF 36 PER SHARE AND STARTS TRADING ON THE SIX SWISS EXCHANGE TOMORROW, FEBRUARY 07, 2025
BioVersys successfully completes its IPO at CHF 36 per share, listing on SIX Swiss Exchange on February 07, 2025. The biopharmaceutical company focuses on antibacterial products against multidrug-resistant bacteria

IPO SIX Swiss Exchange Antibacterial Products BioVersys CHF 36

Published on 01/31/2026 at 03:15, 9 hours 55 minutes ago

Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 10 hours 50 minutes ago

Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 11 hours 30 minutes ago

Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/31/2026 at 00:00, 13 hours 10 minutes ago

BE Resources Announces Private Placement
Published on 01/30/2026 at 23:00, 14 hours 10 minutes ago

Avidian Gold Corp. Announces Director Resignation

View all ACCESSWIRE

Published on 01/31/2026 at 12:25, 44 minutes ago

JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 10 hours 24 minutes ago

CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 15 hours 10 minutes ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 16 hours 59 minutes ago

Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 20:09, 17 hours ago

Aroundtown SA successfully issued AUD 600 million bonds in two tranches

View all EQS

Published on 01/30/2026 at 18:40, 18 hours 30 minutes ago

ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 18:01, 19 hours 9 minutes ago

Emova Group - Résultats annuels 2024/25
Published on 01/30/2026 at 17:45, 19 hours 25 minutes ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 19 hours 25 minutes ago

Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 1 day 4 hours ago

Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés

View all LES ECHOS COMFI WIRE

News